Immutep (IMM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Immutep stock soars on promising trial resultsMay 5 at 9:48 PM | investing.comImmutep Cancer Treatment Shows High Survival RateMay 5 at 9:48 PM | marketwatch.comImmutep Limited: Immutep Quarterly Activities Report Q3 FY25April 30, 2025 | finanznachrichten.deImmutep announces first patient dosed in TACTI-004 Phase III trialMarch 27, 2025 | markets.businessinsider.comHealth Check: Bargain hunters flock to 4D Medical’s discounted raisingMarch 25, 2025 | msn.comImmutep notches upward on first lung cancer patient dosingMarch 25, 2025 | msn.comImmutep announces poster presentation for the TACTI-004 Phase III trialMarch 21, 2025 | markets.businessinsider.comImmutep Ltd (PRRUF) Receives a Buy from Canaccord GenuityMarch 7, 2025 | markets.businessinsider.comWhy Immutep (IMMP) Is Among the Best Australian Stocks to Buy Now?January 27, 2025 | msn.comImmutep announces patient enrollment completed for EFTISARC-NEO Phase II trialJanuary 22, 2025 | markets.businessinsider.comPatient Enrolment Completed for INSIGHT-003January 6, 2025 | finance.yahoo.comImmutep dips as safety test for flagship drug IMP761 shows no adverse effectsDecember 17, 2024 | msn.comImmutep Ltd Reveals Key LAG-3 Binding DiscoveryDecember 16, 2024 | msn.comMolecular insights unlock a targeted approach to cancer immunotherapyDecember 14, 2024 | msn.comASX 300 healthcare stock lifts off on promising new resultsDecember 11, 2024 | msn.comImmutep Ltd Advances Efti in Cancer Treatment TrialsNovember 22, 2024 | markets.businessinsider.comImmutep Limited Passes All AGM ResolutionsNovember 22, 2024 | markets.businessinsider.comImmutep Ltd Sees Increased Stake from Regal FundsNovember 18, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)November 18, 2024 | markets.businessinsider.comImmutep price target raised to $7 from $6 at BairdNovember 17, 2024 | markets.businessinsider.comImmutep Reports Promising Phase II Sarcoma Trial ResultsNovember 16, 2024 | markets.businessinsider.comImmutep Reports Promising Phase II Sarcoma Trial ResultsNovember 16, 2024 | markets.businessinsider.comImmutep’s Promising Lung Cancer Trial ResultsNovember 16, 2024 | markets.businessinsider.comImmutep’s Promising Lung Cancer Trial ResultsNovember 16, 2024 | markets.businessinsider.comImmutep Limited: Immutep's Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung CancerNovember 15, 2024 | finanznachrichten.deImmutep stock jumps 11% on positive data for eftilagimod alphaNovember 15, 2024 | msn.comImmutep announces data from INSIGHT-003 trialNovember 14, 2024 | markets.businessinsider.comImmutep data from Phase II trial presented at CTOSNovember 14, 2024 | markets.businessinsider.comImmutep’s Cancer Trial Shows Promising Survival ResultsNovember 14, 2024 | markets.businessinsider.comImmutep Ltd Reports Promising Results in Sarcoma TrialNovember 14, 2024 | markets.businessinsider.comCanaccord Genuity Sticks to Its Buy Rating for Aroa Biosurgery Ltd (ARX)November 13, 2024 | markets.businessinsider.comCanaccord Genuity Sticks to Its Buy Rating for PYC Therapeutics Limited (PYC)November 13, 2024 | markets.businessinsider.comImmutep reports Q1 cash receipts from custmers $20,000October 29, 2024 | markets.businessinsider.comImmutep Ltd Reports Positive Advances in Cancer TrialsOctober 29, 2024 | markets.businessinsider.comImmutep to Present New Phase IIb Data in PD-L1 Negative (CPS <1) Head and Neck Cancer at ESMO Immuno-Oncology 2024October 28, 2024 | finance.yahoo.comImmutep Faces Cybersecurity Threats: Potential Delays and Liabilities in Product DevelopmentOctober 23, 2024 | markets.businessinsider.comImmutep Limited Announces 2024 AGM DetailsOctober 22, 2024 | markets.businessinsider.comImmutep Limited Announces 2024 Financial PerformanceOctober 22, 2024 | markets.businessinsider.comImmutep Strengthens Transparency with Updated Governance DisclosureOctober 22, 2024 | markets.businessinsider.comImmutep Flat on Test ResultsOctober 17, 2024 | baystreet.caImmutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of TrialOctober 17, 2024 | markets.businessinsider.comImmutep concludes participant enrolment in Phase II breast cancer trialOctober 4, 2024 | msn.comImmutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast CancerOctober 3, 2024 | markets.businessinsider.comHere's why this beaten-up ASX All Ordinaries stock is surging 48% todaySeptember 24, 2024 | msn.comImmutep snaffles A$3.6M from French government for R&DSeptember 24, 2024 | msn.comBuy Rating Affirmed for Immutep on Promising Efti Outlook Despite Mixed Study InterpretationsSeptember 19, 2024 | markets.businessinsider.comWhy Cettire, Immutep, Paladin Energy, and Westgold shares are sinking todaySeptember 15, 2024 | msn.comAlive and Kicking: Respiri promises breath of life to bottom line after inking US distribution dealSeptember 15, 2024 | msn.comImmutep Ltd Webcast Presentation TranscriptSeptember 14, 2024 | gurufocus.comImmutep Ltd Clinical Results Webinar TranscriptSeptember 14, 2024 | gurufocus.com Get Immutep News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address IMM Media Mentions By Week IMM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMM News Sentiment▼-0.250.69▲Average Medical News Sentiment IMM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMM Articles This Week▼31▲IMM Articles Average Week Get Immutep News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GNS News Today ONT News Today BIO News Today ZBIO News Today PRTC News Today OXB News Today FARN News Today FRX News Today NGENF News Today 4BB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IMM) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immutep Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Immutep With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMM Stock Free IMM Stock Alerts